271 related articles for article (PubMed ID: 25384044)
21. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.
Crowe NY; Smyth MJ; Godfrey DI
J Exp Med; 2002 Jul; 196(1):119-27. PubMed ID: 12093876
[TBL] [Abstract][Full Text] [Related]
22. DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.
Shibuya A; Shibuya K
Int Immunol; 2021 Nov; 33(12):687-692. PubMed ID: 34694361
[TBL] [Abstract][Full Text] [Related]
23. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
[TBL] [Abstract][Full Text] [Related]
24. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor.
Tahara-Hanaoka S; Shibuya K; Kai H; Miyamoto A; Morikawa Y; Ohkochi N; Honda S; Shibuya A
Blood; 2006 Feb; 107(4):1491-6. PubMed ID: 16249389
[TBL] [Abstract][Full Text] [Related]
25. Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase.
Inozume T; Yaguchi T; Furuta J; Harada K; Kawakami Y; Shimada S
J Invest Dermatol; 2016 Jan; 136(1):255-63. PubMed ID: 26763445
[TBL] [Abstract][Full Text] [Related]
26. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.
Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A
Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724
[TBL] [Abstract][Full Text] [Related]
27. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.
de Andrade LF; Smyth MJ; Martinet L
Immunol Cell Biol; 2014 Mar; 92(3):237-44. PubMed ID: 24343663
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD226 is associated to but not required for NK cell education.
Wagner AK; Kadri N; Snäll J; Brodin P; Gilfillan S; Colonna M; Bernhardt G; Höglund P; Kärre K; Chambers BJ
Nat Commun; 2017 May; 8():15627. PubMed ID: 28561023
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226.
Liu J; Qian X; Chen Z; Xu X; Gao F; Zhang S; Zhang R; Qi J; Gao GF; Yan J
J Immunol; 2012 Jun; 188(11):5511-20. PubMed ID: 22547693
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.
Fionda C; Abruzzese MP; Zingoni A; Soriani A; Ricci B; Molfetta R; Paolini R; Santoni A; Cippitelli M
BMC Cancer; 2015 Jan; 15():17. PubMed ID: 25609078
[TBL] [Abstract][Full Text] [Related]
31. CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.
Lupo KB; Matosevic S
J Hematol Oncol; 2020 Jun; 13(1):76. PubMed ID: 32532329
[TBL] [Abstract][Full Text] [Related]
32. DNAM-1 promotes inflammation-driven tumor development via enhancing IFN-γ production.
Nakamura-Shinya Y; Iguchi-Manaka A; Murata R; Sato K; Vo AV; Kanemaru K; Shibuya A; Shibuya K
Int Immunol; 2022 Feb; 34(3):149-157. PubMed ID: 34672321
[TBL] [Abstract][Full Text] [Related]
33. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.
Pende D; Castriconi R; Romagnani P; Spaggiari GM; Marcenaro S; Dondero A; Lazzeri E; Lasagni L; Martini S; Rivera P; Capobianco A; Moretta L; Moretta A; Bottino C
Blood; 2006 Mar; 107(5):2030-6. PubMed ID: 16304049
[TBL] [Abstract][Full Text] [Related]
34. Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing.
Kearney CJ; Ramsbottom KM; Voskoboinik I; Darcy PK; Oliaro J
Oncoimmunology; 2016 Aug; 5(8):e1196308. PubMed ID: 27622064
[TBL] [Abstract][Full Text] [Related]
35. CD155/CD226-interaction impacts on the generation of innate CD8(+) thymocytes by regulating iNKT-cell differentiation.
Georgiev H; Ravens I; Shibuya A; Förster R; Bernhardt G
Eur J Immunol; 2016 Apr; 46(4):993-1003. PubMed ID: 26689152
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).
Pende D; Spaggiari GM; Marcenaro S; Martini S; Rivera P; Capobianco A; Falco M; Lanino E; Pierri I; Zambello R; Bacigalupo A; Mingari MC; Moretta A; Moretta L
Blood; 2005 Mar; 105(5):2066-73. PubMed ID: 15536144
[TBL] [Abstract][Full Text] [Related]
37. Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.
Kaito Y; Sugimoto E; Nakamura F; Tsukune Y; Sasaki M; Yui S; Yamaguchi H; Goyama S; Nannya Y; Mitani K; Tamura H; Imai Y
Haematologica; 2024 Apr; 109(4):1107-1120. PubMed ID: 37731380
[TBL] [Abstract][Full Text] [Related]
38. NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.
Wang Y; Chen C; Dong F; Ma S; Xu J; Gong Y; Cheng H; Zhou Y; Cheng T; Hao S
Sci China Life Sci; 2015 Dec; 58(12):1288-98. PubMed ID: 26588911
[TBL] [Abstract][Full Text] [Related]
39. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM
Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
Krelin Y; Voronov E; Dotan S; Elkabets M; Reich E; Fogel M; Huszar M; Iwakura Y; Segal S; Dinarello CA; Apte RN
Cancer Res; 2007 Feb; 67(3):1062-71. PubMed ID: 17283139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
